Kumar Puneet, Kumar Anil
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
J Med Food. 2009 Jun;12(3):591-600. doi: 10.1089/jmf.2008.0028.
Huntington's disease (HD) is a neurodegenerative disorder that results from the destruction of neurons in the basal ganglia, and oxidative stress has been implicated in its pathogenesis. 3-Nitropropionic acid (3-NP), a potent neurotoxin, has been reported to induce oxidative/nitrosative stress and causes neurobehavioral and biochemical changes that mimic HD in humans. It also inhibits complex II of the mitochondrial electron transport chain, thereby causing cellular energy deficit. In the present work, we evaluated the effects of a well-known antioxidant on behavioral, biochemical, and mitochondrial dysfunction induced by 3-NP. The study was designed to investigate the effects of Withania somnifera root extract against 3-NP-induced gait abnormalities, oxidative stress, and mitochondrial dysfunction in striatum and cortex of rat brain. Intraperitoneal administration of 3-NP (10 mg/kg for 14 days) caused a loss in body weight and a decline in motor function (locomotor activity and impaired rotarod activity). Chronic treatment with W. somnifera root extracts (100 and 200 mg/kg) for a period of 2 weeks dose-dependently improved 3-NP-induced behavioral, biochemical, and enzymatic changes (P < .05). Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite and lactate dehydrogenase enzyme levels, depleted antioxidant enzyme (superoxide dismutase and catalase) levels, and blocked ATP synthesis by inhibiting the mitochondrial complex activity in the different regions (striatum and cortex) of the brain. Chronic administration of W. somnifera root extract (100 and 200 mg/kg) dose-dependently restored biochemical alterations induced by chronic 3-NP treatment (P < .05). These findings suggest that neuroprotective actions of W. somnifera are mediated via its antioxidant activity. However, further studies are required to elucidate the molecular mechanisms involved in order to support the clinical use of the plant extract as a therapeutic agent for the treatment of HD.
亨廷顿舞蹈症(HD)是一种神经退行性疾病,由基底神经节中的神经元破坏引起,氧化应激被认为与其发病机制有关。3-硝基丙酸(3-NP)是一种强效神经毒素,据报道可诱导氧化/亚硝化应激,并引起类似于人类HD的神经行为和生化变化。它还抑制线粒体电子传递链的复合物II,从而导致细胞能量缺乏。在本研究中,我们评估了一种著名的抗氧化剂对3-NP诱导的行为、生化和线粒体功能障碍的影响。该研究旨在研究印度人参根提取物对3-NP诱导的大鼠脑纹状体和皮质步态异常、氧化应激和线粒体功能障碍的影响。腹腔注射3-NP(10 mg/kg,持续14天)导致体重减轻和运动功能下降(运动活性和转棒试验活性受损)。用印度人参根提取物(100和200 mg/kg)进行为期2周的慢性治疗,剂量依赖性地改善了3-NP诱导的行为、生化和酶学变化(P < 0.05)。生化分析表明,全身性给予3-NP显著增加脂质过氧化、亚硝酸盐和乳酸脱氢酶水平,消耗抗氧化酶(超氧化物歧化酶和过氧化氢酶)水平,并通过抑制脑不同区域(纹状体和皮质)的线粒体复合物活性来阻断ATP合成。慢性给予印度人参根提取物(100和200 mg/kg)剂量依赖性地恢复了慢性3-NP治疗引起的生化改变(P < 0.05)。这些发现表明,印度人参的神经保护作用是通过其抗氧化活性介导的。然而,需要进一步研究以阐明其中涉及的分子机制,以支持将该植物提取物作为治疗HD的治疗剂的临床应用。
Eur J Pharmacol. 2013-12-10
Methods Find Exp Clin Pharmacol. 2007
J Ayurveda Integr Med. 2025-7-7
Curr Issues Mol Biol. 2024-7-18
J Neural Transm (Vienna). 2024-9
Pharmaceutics. 2023-3-24